Pipilis Athanasios Cardiologist

Doctoral thesis

• MD thesis, University of Athens (1992), The use of captopril and of isosorbide mononitrate in the acute phase of myocardial infarction

Fellowship in Societies, Membership in Journal Editorial Committees

• Member of Hellenic Cardiology Society (HCS) 

• Member of the Board of HCS (1999-2001 and 2003-2005) 

• Special Secretary of the Board of HSC (2001-2003) 

• Fellow of European Society of Cardiology 

• Fellow of American College of Cardiology 

• Chairman of Working Group of Clinical Epidemiology and Prevention of HSC (2002-2004) 

• Member of the Working group of Invasive Cardiology of HSC 

• Member of the Working group of Clinical Epidemiology and Prevention of HSC 

• Member of Hellenic Society of Atherosclerosis 

• Member of the Board of the Hellenic Society of Cardiovascular Health

• Member of Institute for the Study of Thrombosis and Antithrombotic treatment 

• Reviewer of Hellenic Journal of Cardiology 

• Reviewer of International Journal of Cardiology

Work Experience

• SHO and Registrar, Cardiac dept, Guy’s Hospital London (1986-1989)

• Research registrar, Honorary lecturer and senior registrar, John Radcliffe Hospital, Oxford (1989-1992) 

• Senior registrar, Cardiology dept, Hygeia Hospital (1992-1999)

• Deputy Director, Cardiology dept, Hygeia Hospital (1999-2011) 

• Director, Cardiology dept, Hygeia Hospital (2011-to date)

Teaching Experience

• Honorary lecturer, John Radcliffe Hospital, Oxford (1991-1992) 

• Participation in the yearly teaching sessions of post graduate training of the Cardiology Clinic of University of Athens

Clinical & Research Interest

Clinical Interest:

• Clinical Cardiology 

• Acute coronary syndromes 

• Interventional cardiology 

• Antithrombotic treatment in Atrial fibrillation, Acute coronary syndromes

Research Interest:

• Treatments of Acute myocardial infarction (fibrinolysis, antithrombins, antiplatelet therapy) 

• National Registries on atrial fibrillation and Acute myocardial infarction 

• Antithrombotic treatment in Atrial fibrillation 

• Risk prediction charts in primary prevention (National adaptation of HeartScore)

Recent Publications

• Pipilis A, Makrygiannis S, Chrisanthopoulou E, Sourlas N, Kaliambakos S, Ntailianas P. Gastrointestinal bleeding in patients receiving antiplatelet and anticoagulant therapy: practical guidance for restarting therapy and avoiding recurrences. Hellenic J Cardiol. 2014 Nov-Dec;55(6):499-509. PubMed PMID:25432202. 

• Pipilis A, Farmakis D, Kaliambakos S, Antoniou A, Goudevenos J, Lekakis J; RAFTING Investigators. Anticoagulant therapy is prescribed less often in paroxysmal atrial fibrillation regardless of thromboembolic risk: results from the Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING). Int J Cardiol. 2014 Aug 20;175(3):569-70. Doi 10.1016/j.ijcard.2014.05.032. Epub 2014 May 17. PubMed PMID: 24874899. 

• Farmakis D, Pipilis A, Antoniou A, et al. Clinical profile and therapeutic management of patients with atrial fibrillation in Greece: results from the Registry of Atrial Fibrillation to Investigate New Guidelines (RAFTING). Hellenic J Cardiol. 2013 Sep-Oct;54(5):368-75. PubMed PMID: 24100180.

• Pipilis A, Andrikopoulos G, Lekakis J, et al. HELIOS Group. Do we reperfuse those in most need? Clinical characteristics of ST-elevation myocardial infarction patients receiving reperfusion therapy in the countrywide registry HELIOS. Hellenic J Cardiol. 2010 Nov-Dec;51(6):486-91. PubMed PMID: 21169180.

• Pipilis A, Lazaros G, Tsakonas G, Stefanadis C. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting. Hellenic J Cardiol. 2010 Jul-Aug;51(4):330-7. Review. PubMed PMID: 20650831.